New Clinical Trial for PSP
CurePSP and our newly formed Patient Engagement Program (PEP) are excited to announce a new clinical study for patients with a diagnosis of Progressive Supranuclear Palsy (PSP).
The purpose of this study is to see how safe and well tolerated the study drug is at different amounts and to measure the amount of study drug in your blood and cerebrospinal fluid (CSF) after taking the drug. The study will also determine how your immune system reacts to an investigational drug called BMS-986168, and checks other areas of health and disease, such as your daily activities, memory and thinking that may be related with the study drug.
This study will also measure the effect of the study drug on the amount of a protein called Tau present in your cerebrospinal fluid. Tau is a protein normally found in brain cells that is thought to play a role in causing PSP. A key feature of PSP is the build-up of Tau in particular brain regions. Some forms of Tau that are released from brain cells may lead to the spread of Tau in the brain and cause injury to brain cells. BMS-986168 is an investigational antibody hypothesized to specifically bind and remove these forms of Tau.
The length of time for individual participation to complete the trial can last up to 24 weeks following the 6-week screening period. If you qualify for the study, you will be randomly assigned (like a toss of a coin) to receive either study drug or placebo (no active study drug), so there is the possibility that you would not be receiving study drug. After you have completed treatment on this placebo-controlled study, you may qualify to be invited to enter a new study after completion of the week 12 visit where you will receive the active study drug and not placebo. If you do not qualify or do not want to participate in the new study, you will be asked to return for a follow-up visit at week 24.
To participate in this study you must have a reliable caregiver who can come with you to all study visits and who is able to help monitor your health and any medications that you take while you are in the study.
All study related medication or placebo and procedures will be provided at no charge to you.
For more information on this program, please visit ResearchstudyPSP.com or call 855-907-3286.
Thank you for your time and consideration.
Unlocking the Secrets of Brain Disease
800-457-4777 | firstname.lastname@example.org | curepsp.org
Facebook | Twitter | YouTube